Faron Pharmaceuticals Limited (AIM:FARN) has announced its 2025 financial reporting schedule. The financial statement release and 2024 Annual Report are set for February 27, while the half-year financial report for January to June 2025 will be published on August 27.
The company plans to hold its Annual Meeting on March 21, with a formal notice to follow. Faron, based in Turku, Finland, develops novel immunotherapies for cancer treatment.